2.37
price up icon3.04%   0.07
after-market Handel nachbörslich: 2.38 0.010 +0.42%
loading
Schlusskurs vom Vortag:
$2.30
Offen:
$2.33
24-Stunden-Volumen:
121.33K
Relative Volume:
0.67
Marktkapitalisierung:
$7.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.88M
KGV:
-3.16
EPS:
-0.75
Netto-Cashflow:
$-25.20M
1W Leistung:
+9.47%
1M Leistung:
+8.72%
6M Leistung:
-69.34%
1J Leistung:
-90.95%
1-Tages-Spanne:
Value
$2.30
$2.3852
1-Wochen-Bereich:
Value
$2.13
$2.3852
52-Wochen-Spanne:
Value
$2.05
$26.76

In 8 Bio Inc Stock (INAB) Company Profile

Name
Firmenname
In 8 Bio Inc
Name
Telefon
(646) 600-6438
Name
Adresse
EMPIRE STATE BUILDING, NEW YORK
Name
Mitarbeiter
18
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
INAB's Discussions on Twitter

Vergleichen Sie INAB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
INAB
In 8 Bio Inc
2.37 7.46M 0 -31.88M -25.20M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

In 8 Bio Inc Stock (INAB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-03-18 Eingeleitet Laidlaw Buy
2022-08-30 Eingeleitet H.C. Wainwright Buy

In 8 Bio Inc Aktie (INAB) Neueste Nachrichten

pulisher
Jul 20, 2025

What analysts say about 2seventy bio Inc. stockExceptional return forecasts - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - The Globe and Mail

Jul 20, 2025
pulisher
Jul 19, 2025

What drives Mustang Bio Inc. stock priceMarket-leading growth rates - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

What analysts say about TELA Bio Inc. stockBreakout stock performance - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

Upstream Bio, Inc. shares fall 4.98% premarket after HBM Healthcare Investments reports an 8.4% decline in NAV per share. - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

What drives Boundless Bio Inc. stock pricePowerful profit generation - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Gossamer Bio Inc. Stock Analysis and ForecastMarket-leading capital gains - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 15, 2025

Why Climb Bio Inc. stock attracts strong analyst attentionEntry Level Low Risk Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Kronos Bio Inc. stock attracts strong analyst attentionFree Stock Investment Discussion Area - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Why Levi Strauss Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Jul 11, 2025
pulisher
Jul 09, 2025

Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors - GlobeNewswire

Jul 09, 2025
pulisher
Jul 09, 2025

Pre-market Movers: CLDI, BMGL, PROK, RXST... - RTTNews

Jul 09, 2025
pulisher
Jul 09, 2025

KALA BIO Announces Completion of Enrollment in CHASE - GlobeNewswire

Jul 09, 2025
pulisher
Jul 08, 2025

Cizzle Bio Submits NIH Grant Proposal with Premier Research Institutions to Advance Biomarker Blood Test for Lung Cancer - Yahoo Finance

Jul 08, 2025
pulisher
Jul 07, 2025

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma - Yahoo Finance

Jul 07, 2025
pulisher
Jul 07, 2025

KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to - GlobeNewswire

Jul 07, 2025
pulisher
Jun 30, 2025

Clinical-Stage Biotech INmune Bio Secures $19M Through Strategic Share Offering - Stock Titan

Jun 30, 2025
pulisher
Jun 30, 2025

Breakthrough: New Alzheimer's Drug XPro Shows Promise in Key Patient Group, Zero ARIA Cases - Stock Titan

Jun 30, 2025
pulisher
Jun 28, 2025

NUVB SEC FilingsNuvation Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 28, 2025
pulisher
Jun 27, 2025

Clinical-Stage Immunology Company INmune Bio Secures $19M from Healthcare Investors at Market Price - Stock Titan

Jun 27, 2025
pulisher
Jun 26, 2025

Major Alzheimer's Treatment Milestone: INmune Bio Reveals Phase 2 Trial Results Next Week - Stock Titan

Jun 26, 2025
pulisher
Jun 25, 2025

BioCryst's ORLADEYO Pediatric HAE Review Extended by FDA to December 2025 | BCRX SEC FilingForm 8-K - Stock Titan

Jun 25, 2025
pulisher
Jun 23, 2025

Breakthrough in Dementia Treatment: Gene Therapy Maintains 18-Month Efficacy with Lower Dose Success - Stock Titan

Jun 23, 2025
pulisher
Jun 20, 2025

ANVS gains NYSE approval of compliance plan, delisting risk eased | ANVS SEC FilingForm 8-K - Stock Titan

Jun 20, 2025
pulisher
Jun 19, 2025

Global Protein Expression Market to Observe Growth at a CAGR of ~8% by 2032 | DelveInsight - GlobeNewswire

Jun 19, 2025
pulisher
Jun 18, 2025

Nuvation Bio: A Justified Fall Based On Post-Marketing Requirements (NYSE:NUVB) - Seeking Alpha

Jun 18, 2025
pulisher
Jun 11, 2025

U.S. Food and Drug Administration Approves Nuvation Bio's IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer - Quantisnow

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress - Yahoo Finance

Jun 11, 2025
pulisher
Jun 10, 2025

Layoff Tracker: National Resilience Closes 60% of Its Manufacturing Footprint - BioSpace

Jun 10, 2025
pulisher
Jun 10, 2025

Breakthrough: New Drug Reduces Alzheimer's Risk After Brain Injury, DoD-Backed Study Shows - Stock Titan

Jun 10, 2025
pulisher
Jun 09, 2025

IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial - GlobeNewswire Inc.

Jun 09, 2025
pulisher
Jun 03, 2025

European Launch: TELA Bio's Natural Hernia Repair Device Shows 98.8% Success Rate - Stock Titan

Jun 03, 2025
pulisher
Jun 02, 2025

TELA Bio Appoints Jeffrey Blizard as President - GlobeNewswire

Jun 02, 2025
pulisher
May 29, 2025

Pre-market Movers: ALZN, HCTI, REVB, NTLA... - RTTNews

May 29, 2025
pulisher
May 29, 2025

KALA BIO to Present at Jefferies Global Healthcare Conference - GlobeNewswire

May 29, 2025
pulisher
May 28, 2025

Analysts Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $20.33 - MarketBeat

May 28, 2025
pulisher
May 27, 2025

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

Global Immunoprecipitation Market Set to Grow at a CAGR of 6-8%: Key Drivers and Challenges by 2029 - PharmiWeb.com

May 27, 2025
pulisher
May 26, 2025

DNA Polymerase Market to Grow at 6–8% CAGR Driven by Genomics, PCR, and CRISPR Technologies by 2029 - PharmiWeb.com

May 26, 2025
pulisher
May 22, 2025

GRI Bio Presents Positive Pre-Clinical Data Demonstrating - GlobeNewswire

May 22, 2025
pulisher
May 20, 2025

Caisse Française de Financement Local: EMTN 2025-8 SOCIAL - The Manila Times

May 20, 2025
pulisher
May 19, 2025

Protagenic Therapeutics Completes Acquisition of Phytanix Bio - TipRanks

May 19, 2025
pulisher
May 18, 2025

Dimensional Fund Advisors LP Sells 592,968 Shares of bluebird bio, Inc. (NASDAQ:BLUE) - Defense World

May 18, 2025
pulisher
May 14, 2025

KALA BIO: Q1 Earnings Snapshot - The Washington Post

May 14, 2025
pulisher
May 14, 2025

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Raymond James Financial Inc. Takes Position in 8×8, Inc. (NASDAQ:EGHT) - Defense World

May 14, 2025
pulisher
May 13, 2025

Why INmune Bio Inc (INMB) Is Skyrocketing So Far In 2025 - MSN

May 13, 2025
pulisher
May 13, 2025

INmune Bio, Inc. (NASDAQ:INMB) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 12, 2025

Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation - GlobeNewswire

May 12, 2025
pulisher
May 11, 2025

TELA Bio, Inc. (NASDAQ:TELA) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025
pulisher
May 09, 2025

8 Best Medical Simulators On Steam, Ranked - Game Rant

May 09, 2025

Finanzdaten der In 8 Bio Inc-Aktie (INAB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):